Literature DB >> 21928022

Fetal ventriculomegaly: postnatal management.

Kyu-Chang Wang1, Ji Yeoun Lee, Seung-Ki Kim, Ji Hoon Phi, Byung-Kyu Cho.   

Abstract

INTRODUCTION: It is the current status of fetal ventriculomegaly that although the technology for diagnosis is advanced, it does not have significant impact on the management outcome. Fetal ventriculomegaly is mainly treated after birth.
METHODS: We reviewed the literature and suggested policies of postnatal evaluation and surgical management of fetal hydrocephalus. Our experience of 44 cases of fetal ventriculomegaly diagnosed by fetal ultrasonography, in which major poor prognostic factors were absent and for which prenatal pediatric neurosurgical consultation was sought, was also presented.
RESULTS: Our experience showed etiologic heterogeneity of fetal ventriculomegaly although our cases seemed to be surgical candidates more likely than whole group of fetal ventriculomegaly. There were limitations in prenatal evaluation of fetal hydrocephalus. The first step for postnatal management is etiologic classification. It should be clarified after birth whether there is remarkable disturbance of cerebrospinal fluid dynamics or not. The rate of postnatal progression of ventricular dilatation is also important for the decision of treatment plan. For surgical treatment in very young children, special considerations should be paid on technical feasibility, rate of postoperative infection or malfunction, prevention of rapidly developing nervous system from the possible damage, and great plasticity of young brain.
CONCLUSION: Indication, methods, and timing of surgical treatment must be individually tailored according to the etiology, degree and rate of progression of ventriculomegaly, and patient's age when surgical treatment is considered.

Entities:  

Mesh:

Year:  2011        PMID: 21928022     DOI: 10.1007/s00381-011-1556-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric patients: a decision analysis.

Authors:  James M Drake; Abhaya V Kulkarni; John Kestle
Journal:  Childs Nerv Syst       Date:  2009-01-13       Impact factor: 1.475

2.  Etiology, prenatal diagnostics and outcome of ventriculomegaly in 230 cases.

Authors:  József Gábor Joó; Zoltán Tóth; Artúr Beke; Csaba Papp; Erno Tóth-Pál; Akos Csaba; Zsanett Szigeti; Attila Rab; Zoltán Papp
Journal:  Fetal Diagn Ther       Date:  2008-09-02       Impact factor: 2.587

3.  Isolated mild ventriculomegaly: associated karyotypic abnormalities and in utero observations.

Authors:  M W Tomlinson; M C Treadwell; S F Bottoms
Journal:  J Matern Fetal Med       Date:  1997 Jul-Aug

4.  Intrauterine shunt for obstructive hydrocephalus--still not ready.

Authors:  Joseph P Bruner; George Davis; Noel Tulipan
Journal:  Fetal Diagn Ther       Date:  2006-09-12       Impact factor: 2.587

5.  Endoscopic third ventriculostomy for hydrocephalus in children younger than 1 year of age.

Authors:  Essam A Elgamal; Abdel-Azim El-Dawlatly; Waleed R Murshid; Sherif M F El-Watidy; Zain Al-Abedin B Jamjoom
Journal:  Childs Nerv Syst       Date:  2010-08-06       Impact factor: 1.475

6.  Correlation between ventriculomegaly on prenatal magnetic resonance imaging and the need for postnatal ventricular shunt placement.

Authors:  Todd C Hankinson; Monique Vanaman; Peter Kan; Sherelle Laifer-Narin; Robert Delapaz; Neil Feldstein; Richard C E Anderson
Journal:  J Neurosurg Pediatr       Date:  2009-05       Impact factor: 2.375

7.  Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.

Authors:  Tamara D Simon; Matthew Hall; Jay Riva-Cambrin; J Elaine Albert; Howard E Jeffries; Bonnie Lafleur; J Michael Dean; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2009-08       Impact factor: 2.375

8.  Observations regarding failure of cerebrospinal fluid shunts early after implantation.

Authors:  Sherise D Ferguson; Nancy Michael; David M Frim
Journal:  Neurosurg Focus       Date:  2007-04-15       Impact factor: 4.047

9.  Endoscopic third ventriculostomy: outcome analysis in 368 procedures.

Authors:  Oumar Sacko; Sergio Boetto; Valérie Lauwers-Cances; Martin Dupuy; Franck-Emmanuel Roux
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

10.  Ventriculosubgaleal shunt procedure and its long-term outcomes in premature infants with post-hemorrhagic hydrocephalus.

Authors:  Vaner Köksal; Suat Öktem
Journal:  Childs Nerv Syst       Date:  2010-03-19       Impact factor: 1.475

View more
  5 in total

1.  Use of Fetal Magnetic Resonance Image Analysis and Machine Learning to Predict the Need for Postnatal Cerebrospinal Fluid Diversion in Fetal Ventriculomegaly.

Authors:  Jared M Pisapia; Hamed Akbari; Martin Rozycki; Hannah Goldstein; Spyridon Bakas; Saima Rathore; Julie S Moldenhauer; Phillip B Storm; Deborah M Zarnow; Richard C E Anderson; Gregory G Heuer; Christos Davatzikos
Journal:  JAMA Pediatr       Date:  2018-02-01       Impact factor: 16.193

Review 2.  Fetal ventriculomegaly: Diagnosis, treatment, and future directions.

Authors:  Jared M Pisapia; Saurabh Sinha; Deborah M Zarnow; Mark P Johnson; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2017-05-16       Impact factor: 1.475

3.  Postnatal outcome of isolated, nonprogressive, mild borderline fetal ventriculomegaly.

Authors:  Mehmet Serdar Kutuk; Mahmut Tuncay Ozgun; Semih Uludag; Mehmet Dolanbay; Hatice Gamze Poyrazoglu; Mustafa Tas
Journal:  Childs Nerv Syst       Date:  2013-01-11       Impact factor: 1.475

Review 4.  A Comprehensive Review of the Manifestations and Pathogenesis of Zika Virus in Neonates and Adults.

Authors:  Azhar Hussain; Farwa Ali; Omar B Latiwesh; Sheharyar Hussain
Journal:  Cureus       Date:  2018-09-12

Review 5.  Fetal Ventriculomegaly: A Review of Literature.

Authors:  Abdulelah A Alluhaybi; Khalid Altuhaini; Maqsood Ahmad
Journal:  Cureus       Date:  2022-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.